HCA Healthcare
960 hedge funds and large institutions have $42.9B invested in HCA Healthcare in 2022 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 290 increasing their positions, 373 reducing their positions, and 69 closing their positions.
154% more first-time investments, than exits
New positions opened: 175 | Existing positions closed: 69
52% more funds holding in top 10
Funds holding in top 10: 27 → 41 (+14)
26% more capital invested
Capital invested by funds: $34B → $42.9B (+$8.95B)
11% more funds holding
Funds holding: 868 → 960 (+92)
8% less call options, than puts
Call options by funds: $463M | Put options by funds: $503M
1.13% less ownership
Funds ownership: 64.54% → 63.41% (-1.1%)
22% less repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 373
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$388M |
| 2 |
Morgan Stanley
New York
|
+$170M |
| 3 |
JP Morgan Chase
New York
|
+$148M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$83.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$68.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$533M |
| 2 |
Harris Associates
Chicago,
Illinois
|
-$195M |
| 3 |
MAM
Magellan Asset Management
Sydney,
Australia
|
-$101M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$94.3M |
| 5 |
CAM
Crake Asset Management
London,
United Kingdom
|
-$93.5M |
HCA Hedge Fund Activity: Q4 2022 in Review
960 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2022, worth a combined $42.9B — up 26% from $34B a quarter earlier.
Buyers outnumbered sellers: 175 funds opened new HCA positions and 69 closed out — a net gain of 106 holders — while 290 added to existing stakes and 373 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $388M. The largest seller was Fidelity Investments, cutting an estimated $533M.
- 960 institutional investors held HCA Healthcare (HCA) as of Q4 2022, up from 868 in Q3 2022.
- Funds reported $42.9B of HCA Healthcare stock for Q4 2022, up 26% quarter-over-quarter.
- 175 funds opened new HCA Healthcare positions in Q4 2022 and 69 closed out, a net change of +106 holders.
- The largest HCA Healthcare buyer in Q4 2022 was T. Rowe Price Associates, an estimated $388M added.
- The largest HCA Healthcare seller in Q4 2022 was Fidelity Investments, an estimated $533M sold.
Based on aggregated 13F filings for Q4 2022.